Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2012;7(11):e43937.
doi: 10.1371/journal.pone.0043937. Epub 2012 Oct 11.

An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients

Affiliations
Clinical Trial

An analysis of regulatory T-cell and Th-17 cell dynamics during cytomegalovirus replication in solid organ transplant recipients

Adrian Egli et al. PLoS One. 2012.

Abstract

Background: CMV-specific T-cells are crucial to control CMV-replication post-transplant. Regulatory T-cells (T-regs) are associated with a tolerant immune state and may contribute to CMV-replication. However, T-cell subsets such as T-regs and IL-17 producing T-cells (Th-17) are not well studied in this context. We explored T-regs and Th-17 frequencies during CMV-replication after transplantation.

Methods: We prospectively evaluated 30 transplant patients with CMV-viremia. We quantified CMV-specific CD4(+) and CD8(+) T-cells, T-regs (CD4(+)CD25(+)FoxP3(+)) and Th-17 frequencies using flow-cytometry and followed patients requiring anti-viral treatment. Two subsets were compared: anti-viral treatment requirement (n = 20) vs. spontaneous clearance of viremia (n = 10).

Results: Higher initial CMV-specific CD4(+) T-cells and lower T-regs were observed in patients with spontaneous clearance (p = 0.043; p = 0.021 respectively). Using a ratio of CMV-specific CD4(+) T-cells to T-regs allowed prediction of viral clearance with 80% sensitivity and 90% specificity (p = 0.001). One month after stop of treatment, the same correlation was observed in patients protected from CMV-relapse. The ratio of CMV-specific CD4(+) T-cells to T-regs allowed prediction of relapse with 85% sensitivity and 86% specificity (p = 0.004). Th-17 responses were not correlated with virologic outcomes.

Conclusions: This study provides novel insights into T-regs and Th-17 subpopulations during CMV-replication after transplantation. These preliminary data suggest that measurement of CMV-specific CD4(+) T-cells together with T-regs has value in predicting spontaneous clearance of viremia and relapse.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have read the journal's policy and have the following conflicts: D.K. and A.H. have received research support from Hoffmann-LaRoche and Cellestis Inc. The support from Hoffmann-LaRoche and Cellestis Inc. was not for this specific study. The other authors have no conflict of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.

Figures

Figure 1
Figure 1. CMV-specific CD4+ and CD8+ T-cell, T-reg and Th-17 dynamics in patients with different viral outcomes.
Square (□) indicates CMV-specific CD4+ T-cell response. Circle (○) indicates CMV-specific CD8+ T-cell response. Triangle (▵) indicates T-reg response. Diamond (⋄) indicates Th-17 response. Black bar indicates median value, whiskers indicate inter-quartile range. (A), patients with spontaneous clearance of viremia compared with patients with progressive viral-loads who commenced treatment. Initial immune response at treatment commencement was determined. (B), patients with relapse compared to patients without relapse. Immune responses as determined 1 month after treatment discontinuation.
Figure 2
Figure 2. Receiver operating characteristic (ROC) curve analysis of CMV-specific CD4+ T-cells and T-regs to predict virus clearance and development of relapse.
ROC curves were generated by analyzing the sensitivity and specificity of different cut-points for defining a positive test result and their ability to predict the outcome of interest. For Figure 2A, 2B, and 2C, the outcome of interest is spontaneous clearance of viremia [vs. progression]; n = 30. For Figure 2D, 2E, and 2F, the outcome is relapse of CMV after completion of treatment [n = 20]. The following three tests were analyzed: CMV-specific CD4+ T-cell response [Figure 2A and 2D], T-reg response [Figure 2B and 2E] and the ratio of the CMV-specific CD4+ T-cells to T-reg response [Figure 2C and 2F]. To determine the sensitivity and specificity for predicting clearance of viremia we used baseline immune measurements (2A, 2B, and 2C); for prediction of relapse we used measurements one month after completing treatment (2D, 2E, and 2F).

References

    1. Humar A, Snydman D (2009) Cytomegalovirus in solid organ transplant recipients. Am J Transplant 9 Suppl 4: S78–86. - PubMed
    1. Freeman RB Jr (2009) The ‘indirect’ effects of cytomegalovirus infection. Am J Transplant 9: 2453–2458. - PubMed
    1. Bunde T, Kirchner A, Hoffmeister B, Habedank D, Hetzer R, et al. (2005) Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 201: 1031–1036. - PMC - PubMed
    1. Egli A, Binet I, Binggeli S, Jager C, Dumoulin A, et al. (2008) Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients. J Transl Med 6: 29. - PMC - PubMed
    1. Gerna G, Lilleri D, Fornara C, Comolli G, Lozza L, et al. (2006) Monitoring of human cytomegalovirus-specific CD4 and CD8 T-cell immunity in patients receiving solid organ transplantation. Am J Transplant 6: 2356–2364. - PubMed

Publication types

MeSH terms